HCN Investigates: What Will the Cannabinoid Market Look Like in 2025?

6.4 min readPublished On: February 19th, 2021By

If you had known ahead of time that the domestic CBD market would explode in 2017, what would you have done differently? There’s no need to wonder—a new opportunity is now arising that could completely eclipse the CBD boom we’ve witnessed over the last few years. 

Due to advanced breeding and extraction technologies, it’s now possible to produce all the eight major cannabinoids in large quantities, facilitating the rise of CBG, CBN, CBC, and other non-intoxicating cannabinoids as genuine CBD competitors. We predict that the cannabinoid market of 2025 will be so different from today’s industry as to be almost unrecognizable, and here’s what you need to know to position yourself and prepare.

The ice cream shop approach to cannabinoids

If like most people, you’ve gotten interested in the cannabinoid industry over the last few years, you’re used to THC, CBD, and perhaps, CBG being the only cannabis constituents that are widely available. All that is about to change, however—if it hasn’t changed already.

Long before we reach 2025, consumers will already be demanding access to the whole spectrum of cannabinoids available in hemp. When you go into an ice cream shop, you expect to have more than just chocolate and vanilla as your flavor choices. To be successful, ice cream shops have to offer a dozen flavors or more, and the same will soon be true for cannabinoid manufacturers.

What are the health benefits of consuming CBG, CBC, and CBN?

Instead of offering diverse flavors like ice cream, the different cannabinoids in hemp each offer unique experiences and benefits. In the form of terpenes, flavonoids, and cannabinoids, hemp contains hundreds of different oils, and each oil has different attributes and potential applications. Let’s examine how three of the most promising new cannabinoids are different from CBD to give you a basic overview:

How is CBG different from CBD?

While most people use CBD for pain and psychological distress, the consumers of 2025 will use cannabigerol (CBG) for immune protection and digestive disturbance. Many of the benefits of CBD and CBG overlap—for instance, both cannabinoids are non-psychoactive, and they are commonly used for oxidative stress and inflammation. CBG appears to be the only cannabinoid, however, to exert direct immune modulation, and it’s also being looked at as a treatment for irritable bowel syndrome (IBS) and Crohn’s disease.

How is CBC different from CBD?

What are the effects of CBC? Consumers are already taking note of some of the published studies on cannabichromene (CBC), and they’re using this cannabinoid in the hopes that it will protect them from cancer. They also use CBC for some of the same purposes as CBD, such as alleviation of oxidative stress. Remember that the benefits of CBC that overlap with CBD only make these two cannabinoids stronger when combined.

How is CBN different from CBD?

Like CBG and CBC, cannabinol (CBN) is more similar to CBD than it is different. Where CBN is unique, however, is in its potential applications for sleep. Already, consumers are looking to CBN products as alternatives to melatonin and other natural sleep aids. Out of all the new cannabinoids, it’s perhaps CBN that holds the most promise as an addition to CBD products, which consumers already regularly use for sleep.

Can I take CBN with CBD or THC?

Taking advantage of the synergy between cannabinoids will prove a key aspect of marketing CBN as more brands start offering this new hemp constituent, so you should know that none of the cannabinoids are known to cause harmful interactions with each other. In fact, non-intoxicating cannabinoids, like CBN, may reduce the less-desirable effects of THC.

Should I take CBG, CBC, and CBN together?

As we enter a new era of cannabinoid marketing, consumers will need to understand that cannabinoids are not exclusive of each other. The more cannabinoids you use, the more effective each cannabinoid becomes, which is a critical element of expressing the value of using non-intoxicating cannabinoids aside from CBD. Rather than introducing a bunch of new cannabis substances that muddy the waters due to their similarity, it’s essential to express that CBG, CBN, and CBC make CBD (and each other) more effective.

How to build a brand that incorporates the new cannabinoids

Since there’s so much competition, it’s almost too late to start a brand that focuses solely on CBD. Cannabinoid brands of the future will need to incorporate the unique benefits of all the hemp constituents we’ve listed above, and it’s likely that CBDA, THCV, and other non-intoxicating cannabinoids will also play key roles. Now that you understand the place that each new cannabinoid will take in the hemp pantheon, you should learn how to build a hemp brand that will stand the test of time:

Understanding the entourage effect

Marketing cannabinoids in 2025 will be all about expressing how all the non-intoxicating hemp constituents work together. Known as the entourage effect, a promising synergy between cannabinoids, terpenes, and other hemp constituents has become an increasingly hot topic over the next few years, and learning how to market new cannabinoids using the entourage effect will be critical to helping consumers understand why they need to use CBG, CBC, and CBN in addition to CBD.

Incorporating consumer education

Not so long ago, the consumer population was forced to accept that cannabis doesn’t have to be intoxicating, which required a huge shift in sentiment. Now, even more, non-intoxicating cannabinoids are entering the scene, and consumers won’t buy what they don’t understand. 

 

As a brand, it will be your job to express the benefits of each new cannabinoid to your customers. That means educating yourself and your team by reading studies and accumulating anecdotal evidence. The more educated you are on the cannabinoids you’re selling, the more successful you’ll be in building your multi-cannabinoid brand.

Finding the right supplier

Over the next few years, CBG, CBC, and CBN will become more widely available, and they’ll also be in much higher demand. As a result, the existing cannabinoid market will expand greatly, rewarding good actors and punishing opportunists who don’t know how to reliably produce cannabinoids over the long term.

Scouting the right cannabinoid supplier is essential whether you plan to start a brand right now or you’d rather wait to see where the industry leads. A supplier that looks great today could go bankrupt tomorrow, so it’s important to prioritize brands that have longevity and focus on professionalism. Third-party lab results are a must, and producers that encourage tours of their facilities offer transparency, which is a virtue in short supply among brands that simply want to get rich quick.

Prepare for the future by embracing new cannabinoids

CBD wasn’t a fad—it was a foot in the door. Now that the consumer population has accepted CBD into the natural health market, other hemp constituents are sure to follow. Failing to recognize this major industry shift will lead to missed opportunities both in the long and short term.

In 2025, CBD might still be the lynchpin around which all the other non-intoxicating cannabinoids orbit, or it might have been supplanted by CBG, CBC, or CBN. There’s no way to tell, but what’s certain is that the new cannabinoids are destined for the same fate as CBD—international stardom and ever-increasing demand.

Five years from now may seem a long way away, but in fact, it’s just around the corner. Prepare today by deciding how you’ll incorporate CBG, CBC, and CBN into your new hemp product line.

About the Author: News Team

Newsteam at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!

Latest News

ACS Laboratory Announces New THCOa Safety Bundle

January 19th, 2022|

BOCA RATON, Fla. - ACS Laboratory, hemp and cannabis testing facility in the eastern U.S., has developed the THCOa Safety Bundle Test, a testing panel to test for THC-O Acetate (THCOa), acetic anhydride and other ...

Curaleaf Completes Acquisition of Bloom Dispensaries

January 19th, 2022|

WAKEFIELD, Mass. - Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF), an international provider of consumer products in cannabis, announced the completion of its previously announced acquisition of Bloom Dispensaries, a single state cannabis operator ...